Monitor CFO integration and upcoming financial guidance for signs of strategic direction changes. The equity grants represent potential dilution of approximately 1.3% of current market cap.
Price Chart
Executive Summary
Prime Medicine appointed Svetlana Makhni as CFO effective April 16, 2026, with a $495,000 base salary, 40% bonus target, $40,000 sign-on bonus, and options to purchase 900,000 shares. CEO Allan Reine stepped down from the principal financial officer role.
Key Facts
- Svetlana Makhni appointed CFO effective April 16, 2026
- Annual base salary of $495,000 with 40% target bonus
- Sign-on bonus of $40,000
- Time-based option grant for 800,000 shares vesting over 4 years
- Milestone-based option grant for 100,000 shares
- Allan Reine stepped down as principal financial officer
- Employment agreement includes severance of 9 months base salary plus 75% of target bonus if terminated without cause
Financial Impact
Approximately $3.96 million in potential compensation over 4 years including salary, target bonus, sign-on bonus, and equity grants based on current market value
Risk Factors
- Integration risk with new CFO
- Potential dilution from equity grants
- Leadership transition in key financial role
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-025372 |
| Document: prme-20260407.htm | 0001628280-26-025372 |
| Document: 0001628280-26-025372-index-headers.html | 0001628280-26-025372 |
| Document: 0001628280-26-025372-index.html | 0001628280-26-025372 |
| Document: 0001628280-26-025372.txt | 0001628280-26-025372 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 24, 2026 4w ago | Press Release | $2.90 | awaiting T+60 | — | $4.35 (+50.00%) |
Aug 6, 2026 11w ago | 8-K | $2.95 | awaiting T+60 | — | $4.35 (+47.46%) |
Jul 8, 2026 15w ago | 8-K | $4.62 $3.06 | ▼ −33.87% | ▼ −36.19% | $4.35 (−5.84%) |
Jun 18, 2026 18w ago | Press Release | $3.23 $3.18 | ▼ −1.55% | ▼ −3.44% | $4.35 (+34.67%) |
May 7, 2026 24w ago | 8-K | $3.12 $2.81 | ▲ +9.79% | ▲ +13.62% | $4.35 (−39.65%) |
May 7, 2026 24w ago | Press Release | $3.12 $2.81 | ▲ +9.79% | ▲ +13.62% | $4.35 (−39.65%) |
Apr 16, 2026 27w ago | 8-K | $3.67 $3.52 | ▼ −4.22% | ▼ −11.27% | $4.35 (+18.53%) |
Mar 3, 2026 34w ago | Press Release | $4.23 $3.30 | ▼ −21.99% | ▼ −32.30% | $4.35 (+2.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers